Tiziana Life Sciences (TLSA) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Tiziana Life Sciences Ltd. has announced the voluntary resignation of its Chief Operating Officer and Chief Medical Officer, Matthew W Davis, MD, RPh, effective from August 2, 2024. The departure is due to personal reasons, with no reported disputes concerning company operations, policies, or practices. A search for Dr. Davis’ successor is underway, with further updates to come once a replacement is appointed.
For further insights into TLSA stock, check out TipRanks’ Stock Analysis page.
